Dentsply Sirona Reports First Quarter 2016 Results

Go back to Dentsply Sirona Reports First Quarter 2016 Results

UBS Raises Price Target on Dentsply Int'l (XRAY) Following 1Q and Guidance

May 9, 2016 8:12 AM EDT

UBS reiterated a Neutral rating on Dentsply International (NASDAQ: XRAY), and raised the price target to $64.00 (from $60.00), following the company's 1Q earnings report. The company's solid results were driven by CAD/CAM and operatory focused consumables. Sales guidance for 2016 was provided for the first time of 4-6% CC growth, which translates into... More

Dentsply Int'l (XRAY) Tops Q1 EPS by 7c

May 6, 2016 6:07 AM EDT

Dentsply Int'l (NASDAQ: XRAY) reported Q1 EPS of $0.70, $0.07 better than the analyst estimate of $0.63. Revenue for the quarter came in at $772.6 million versus the consensus estimate of $741.8 million.

GUIDANCE:

Dentsply Int'l sees FY2016 EPS of $2.70-$2.80, versus the consensus of... More